EKF Diagnostics (LON:EKF) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why

EKF Diagnostics Holdings plc (LON:EKF)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 26.75 and traded as high as GBX 26.90. EKF Diagnostics shares last traded at GBX 26.90, with a volume of 120,097 shares trading hands.

EKF Diagnostics Stock Performance

The company has a 50 day simple moving average of GBX 25.98 and a 200 day simple moving average of GBX 26.75. The company has a quick ratio of 1.77, a current ratio of 4.62 and a debt-to-equity ratio of 1.56. The stock has a market cap of £116.16 million, a price-to-earnings ratio of 19.93 and a beta of 0.53.

Insider Buying and Selling

In related news, insider Julian Baines acquired 85,000 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was acquired at an average price of GBX 23 per share, with a total value of £19,550. 39.73% of the stock is currently owned by insiders.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.